Literature DB >> 28344984

Advance Directive in End of Life Decision-Making among the Yoruba of South-Western Nigeria.

Ayodele Samuel Jegede1, Olufunke Olufunsho Adegoke2.   

Abstract

End-of-life decision making is value-laden within the context of culture and bioethics. Also, ethics committee role is difficult to understand on this, thus need for ethnomethodological perspective in an expanding bioethical age. Anthropological approach was utilized to document Yoruba definition and perspective of death, cultural beliefs about end-of-life decision making, factors influencing it and ethics committee role. Interviews were conducted among selected Yoruba resident in Akinyele LGA, Oyo State, Nigeria. Content analytical approach was used for data analysis. Yoruba culture, death is socially constructed having spiritual, physical and social significance. Relationship between the dying and significant others influences decision making. Hierarchy of authority informs implementing traditional advance directive. Socialization, gender, patriarchy, religious belief and tradition are major considerations in end-of-life decision making. Awareness, resource allocation and advocacy are important ethics committees' roles. Further research into cultural diversity of end-of-life decision making will strengthen ethical practice in health care delivery.

Entities:  

Keywords:  Advance Directive; End-of-Life Decision Making; Ethics; Ethnomethodology; Nigeria; Yoruba

Year:  2016        PMID: 28344984      PMCID: PMC5363404          DOI: 10.20541/beonline.2016.0008

Source DB:  PubMed          Journal:  BEOnline


  40 in total

1.  Advanced directives, the right to die and the common law: recent problems with blood transfusions.

Authors:  C Stewart
Journal:  Melb Univ Law Rev       Date:  1999-04

2.  Advance directives and the persistent vegetative state in Victoria: a human rights perspective.

Authors:  Deborah Porter
Journal:  J Law Med       Date:  2005-11

3.  Ethnicity and advance care directives.

Authors:  S T Murphy; J M Palmer; S Azen; G Frank; V Michel; L J Blackhall
Journal:  J Law Med Ethics       Date:  1996       Impact factor: 1.718

4.  To save or let die. The dilemma of modern medicine.

Authors:  R A McCormick
Journal:  JAMA       Date:  1974-07-08       Impact factor: 56.272

5.  Negotiating cross-cultural issues at the end of life: "You got to go where he lives".

Authors:  M Kagawa-Singer; L J Blackhall
Journal:  JAMA       Date:  2001-12-19       Impact factor: 56.272

6.  Living wills and advance directives in South African Law.

Authors:  Andrew Skeen
Journal:  Med Law       Date:  2004

7.  Improving end-of-life experience and care in the community: a conceptual framework.

Authors:  I Byock; K Norris; J R Curtis; D L Patrick
Journal:  J Pain Symptom Manage       Date:  2001-09       Impact factor: 3.612

8.  Seven legal barriers to end-of-life care: myths, realities, and grains of truth.

Authors:  A Meisel; L Snyder; T Quill
Journal:  JAMA       Date:  2000-11-15       Impact factor: 56.272

9.  Criteria for priority-setting in health care in Uganda: exploration of stakeholders' values.

Authors:  Lydia Kapiriri; Ole Frithjof Norheim
Journal:  Bull World Health Organ       Date:  2004-04-16       Impact factor: 9.408

10.  Ethical dilemmas in a cross-cultural context. A Chinese example.

Authors:  J H Muller; B Desmond
Journal:  West J Med       Date:  1992-09
View more
  2 in total

1.  Older persons' perceptions about advanced directives and end of life issues in a geriatric care setting in Southwestern Nigeria.

Authors:  Eniola Olubukola Cadmus; Lawrence Adekunle Adebusoye; Olufemi Oluwole Olowookere; Adebowale Taiwo Olusegun; Oluwagbemiga Oyinlola; Raimi Olalekan Adeleke; Olubukola Christianah Omobowale; Temitope Oluwagbenga Alonge
Journal:  Pan Afr Med J       Date:  2019-02-05

2.  A quantitative study of nurses perception to advance directive in selected private and public secondary healthcare facilities in Ibadan, Nigeria.

Authors:  Oluwaseyi Emiola Ojedoyin; Ayodele Samuel Jegede
Journal:  BMC Med Ethics       Date:  2022-08-25       Impact factor: 2.834

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.